ARCHIVES

Clinical Trials: “Master Protocol” To Rely On Biomarkers In Testing Multiple Lung Cancer Agents

This article is from The Cancer Letter archive.

Vol. 39 No. 43 | November 15, 2013

Download PDF Visit The Full Archive

Related Articles

First Lady Recalls 1992 Meeting With NBCC, Credits Group For Progress In Breast Cancer

May 8, 1998

NCI Plans Progress Review In Lymphoma This Year.

March 10, 2000

Cell Phone Radiation Does Not Raise Child’s Risk of Tumors

August 26, 2011

Study Begins On Link Between Down Syndrome, Leukemia

May 28, 2004

In Brief: Bishop No Longer Candidate For NCI Director; HHS Endorses Intramural Scientist Klausner

April 21, 1995

NCCN in Transition: New Strategy to Examine Role of Informatics, Revenue Sources and International Programs

June 15, 2012